CMS launches 10-year Medicare model to pay AI chronic care agents

Medicare is drawing the first real reimbursement map for AI chronic care agents while much of the tech industry is still building products without a clear way to get paid. CMS said its new ACCESS model will let Original Medicare pay for technology-supported chronic care through outcome-based payments, creating a pathway for services that can monitor a patient between visits, check in by phone, coordinate a housing referral, or make sure a prescription is picked up.

The 10-year voluntary test begins July 5, 2026, and it is built around what CMS calls Outcome-Aligned Payments, a structure that rewards results rather than a checklist of required activities. Full payment will depend on measurable health gains, including blood-pressure improvement or control for people with hypertension. CMS said the model targets conditions that affect more than two-thirds of Medicare beneficiaries, including high blood pressure, diabetes, chronic musculoskeletal pain and depression, which puts some of the program’s earliest gains in reach for millions of older adults and people with disability coverage.

The model arrives after years of narrower Medicare payments for non-face-to-face care. CMS launched Chronic Care Management services in 2015 and later expanded reimbursement for remote physiologic monitoring codes beginning in 2019, adding another RPM code in 2020. ACCESS goes further by recognizing a broader range of software-driven, AI-supported longitudinal care, including telehealth, wearable monitoring devices and digital coaching tools that the American Medical Association said could modernize chronic disease management for patients who have traditionally faced barriers to technology-enabled care.

For technology companies, the new rules may matter as much as the clinical promise. More than 350 technology-enabled care organizations had already submitted intent to apply, and CMS said more than 150 digital health companies were approved for the launch cohort. Private payers representing 165 million Americans across Medicare Advantage, Medicaid and commercial coverage have also pledged to align with ACCESS-style outcome-based payments, a sign that the Medicare model could shape broader market behavior if it works.

But the barriers are still significant. Participating organizations must be enrolled in Medicare Part B, comply with licensure and privacy-security rules, and designate a physician clinical director responsible for quality and compliance. CMS set a first-cohort deadline of May 15, 2026, with later applications considered for a January 1, 2027, start. The model may be the clearest sign yet that AI chronic care is moving from demos to reimbursement, but only organizations able to prove measurable results will get the strongest footing.